Ke Liu

Title: Ke Liu - Innovator in Amphiphilic Block Copolymers

Introduction

Ke Liu is a prominent inventor based in Suzhou, China. He has made significant contributions to the field of nanomedicine, particularly through his innovative work on amphiphilic block copolymers. His research focuses on developing drug delivery systems that enhance the efficacy of antitumor treatments.

Latest Patents

Ke Liu holds a patent for an "Amphiphilic block copolymer and preparation method thereof and micellar drug-loading system formed by same with antitumor drug." This invention relates to a novel amphiphilic block copolymer that comprises a hydrophilic segment and a hydrophobic segment. The end group of the hydrophobic segment is end-capped with a hydrophobic group. The copolymer utilizes methoxypolyethylene glycol (or polyethylene glycol)-polyester block copolymer, which is recognized for its safety. The terminal hydroxyl group of the polyester segment is modified with a hydrophobic group, improving compatibility between the drug molecule and the hydrophobic segments of the block copolymer. This innovation provides a larger space for accommodating drug molecules, resulting in a drug-loaded micelle with high stability.

Career Highlights

Throughout his career, Ke Liu has worked with notable companies in the field of nanomedicine. He has been associated with Suzhou Nanomedicine R&D Co., Ltd. and Changzhou Target Medicine Technology Co., Limited. His work has significantly advanced the development of drug delivery systems.

Collaborations

Ke Liu has collaborated with esteemed colleagues, including Feirong Gong and Hui Xu. Their combined expertise has contributed to the success of their research endeavors.

Conclusion

Ke Liu's innovative work in amphiphilic block copolymers represents a significant advancement in drug delivery systems for antitumor therapies. His contributions continue to impact the field of nanomedicine positively.